As of 3:30pm ET
| +0.34 / +0.32%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 105.00, with a high estimate of 135.00 and a low estimate of 94.00. The median estimate represents a -2.89% decrease from the last price of 108.12.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since July, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.